Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1960-1962
doi: 10.1161/01.ATV.0000096608.44578.D9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, M. J.
Right arrow Articles by Sigmund, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, M. J.
Right arrow Articles by Sigmund, C. D.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1960.)
© 2003 American Heart Association, Inc.


Editorials

HPRT Targeting

"Ets" A Powerful Tool For Investigating Endothelial-Cell Specific Gene Expression

Michael J. Ryan; Curt D. Sigmund

From the Department of Medicine and Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City.

Address correspondence to Curt D. Sigmund, PhD, Professor Department of Internal Medicine, 3181 MERF, University of Iowa, Department of Internal Medicine, Iowa City, IA 52242. E-mail Curt-Sigmund@uiowa.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Elucidating the role of genes that are important for the development of the vascular endothelium and their time course of expression throughout ontogeny is an important and exciting area of ongoing investigation. In addition to advances that can be made to better understand the vasculature from a developmental perspective, there are obvious clinical implications from determining how gene expression in the endothelium participates in blood vessel formation and function. For example, since tumors require an adequate supply of blood to proliferate, there is a tremendous interest in uncovering mechanisms controlling vascularization and angiogenesis. Moreover, enhancing our understanding of the regulation of gene expression in the blood vessel wall has clear clinical implications for improving collateral blood vessel formation in tissues after an ischemic insult and in peripheral vascular disease.

See page 2041

One of the most common methods to experimentally examine how a gene is regulated is by "promoter bashing." Promoter bashing is usually performed by transient transfection of recombinant DNA constructs consisting of the 5' flanking region of the gene of interest fused to easily assayable reporter genes such as luciferase or LacZ. The presumption is that the 5' flanking sequence contains regulatory elements vital to the control of transcriptional activity that are required for targeting cell-specific expression. Systematic deletions or mutations created in the construct with subsequent evaluation of their effects on reporter gene activity, coupled with molecular assays designed to identify cognate transcription factors, has been a powerful approach to identify regulatory elements and proteins regulating gene . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
G. Palais, A. Nguyen Dinh Cat, H. Friedman, N. Panek-Huet, A. Millet, F. Tronche, B. Gellen, J.-J. Mercadier, A. Peterson, and F. Jaisser
Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system
Physiol Genomics, April 10, 2009; 37(2): 140 - 146.
[Abstract] [Full Text] [PDF]